XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash Flows From Operating Activities    
Net income $ 13,331 $ 22,393
Adjustments to reconcile net income to net cash provided by operating activities    
Net accretion of bond premium 3,701 3,981
Depreciation and amortization 2,295 1,785
Stock-based compensation expense 437 411
Net realized investment gains (2,194) (1,909)
Net cash flows from trading investments (5,673) 46
Deferred income tax expense (benefit) (1,559) 460
Changes in:    
Accrued investment income (763) 296
Premiums receivable (17,789) (19,631)
Deferred policy acquisition costs (2,124) (2,917)
Reinsurance receivables 2,170 (5,741)
Prepaid reinsurance premiums (470) (255)
Income taxes receivable 1,786 14,150
Other assets 2,324 1,013
Future policy benefits and losses, claims and loss settlement expenses 19,648 6,364
Unearned premiums 20,318 14,670
Accrued expenses and other liabilities (17,785) (5,068)
Income taxes payable 1,948 0
Deferred income taxes (72) 1,665
Other, net (1,038) 31
Total adjustments 5,160 9,351
Net cash provided by operating activities 18,491 31,744
Cash Flows From Investing Activities    
Proceeds from sale of available-for-sale investments 0 2,810
Proceeds from call and maturity of held-to-maturity investments 11 19
Proceeds from call and maturity of available-for-sale investments 103,480 127,514
Proceeds from short-term and other investments 764 407
Purchase of available-for-sale investments (131,989) (142,615)
Purchase of short-term and other investments (1,152) (900)
Net purchases and sales of property and equipment (2,860) (386)
Net cash used in investing activities (31,746) (13,151)
Policyholders’ account balances    
Deposits to investment and universal life contracts 49,281 25,369
Withdrawals from investment and universal life contracts (55,882) (46,219)
Payment of cash dividends (4,567) (3,786)
Issuance of common stock 823 603
Tax impact from issuance of common stock 70 (78)
Net cash used in financing activities (10,275) (24,111)
Net Change in Cash and Cash Equivalents (23,530) (5,518)
Cash and Cash Equivalents at Beginning of Period 92,193 107,466
Cash and Cash Equivalents at End of Period $ 68,663 $ 101,948